Discordant Treatment Effects According to Menopausal Status Following Adjuvant Zoledronic Acid in Stage II/III Breast Cancer - The AZURE Trial (BIG 01/04)

被引：1

作者：

Coleman, R. ^{[1
]}

Marshall, H. ^{[2
]}

Gregory, W. ^{[2
]}

Bell, R. ^{[3
]}

Dodwell, D. ^{[4
]}

Keane, M. ^{[5
]}

Gil, M. ^{[6
]}

Davies, C. ^{[2
]}

Cameron, D. ^{[7
]}

机构：

[1] Univ Sheffield, Weston Pk Hosp, Canc Clin Trials Ctr, Sheffield, S Yorkshire, England

[2] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England

[3] Andrew Love Canc Ctr, Geelong, Vic, Australia

[4] Univ Leeds, St James Inst Oncol, Leeds, W Yorkshire, England

[5] Univ Hosp Galway, Galway, Ireland

[6] 6 Inst Catala Oncol IDIBELL, Barcelona, Spain

[7] Univ Edinburgh, Western Gen Hosp, Med Oncol Unit, Edinburgh, Midlothian, Scotland

来源：

关键词：

D O I：

10.1016/S0959-8049(11)71461-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S336 / S336

页数：1